Vsling device for ventricular repair in heart failure
Part of Heart & circulation clinical trials.
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your heart's pumping ability (ejection fraction) needs to be between 20% and 40%.
- Your heart's main pumping chamber must be enlarged (left ventricle >55 mm in diameter when relaxed).
- You cannot have had any mitral valve surgery or repair in the past.
- You cannot have had a dangerous heart rhythm episode (ventricular tachycardia) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called Vsling™, which is placed inside the heart to help it pump better in people with heart failure. The device aims to reshape the heart's main pumping chamber, which may improve your symptoms and quality of life.
This trial tests a new device that is placed using a thin tube through a vein in the leg to repair a leaky mitral valve in people with heart failure. The goal is to see if it can reduce symptoms and improve quality of life beyond what usual medications can do.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
This trial tests a less invasive procedure to reshape the heart in people with heart failure due to a scar or aneurysm. It aims to improve heart function and symptoms.
This trial tests a small device placed in the heart to help reduce fluid buildup and ease breathing in people with advanced heart failure. It might help you feel better and avoid hospital stays.
This trial is testing a new device to help people with severe mitral regurgitation (a leaky heart valve) who cannot have open-heart surgery or a valve clip. The device is placed using a thin tube through a blood vessel, and aims to improve symptoms and quality of life.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.